obiltoxaximab
General
Pronunciation:
oh-bil-tox-ax-i-mab
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Anthim
Ther. Class.
antidotes
Pharm. Class.
monoclonal anti-toxins
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Obiltoxaximab." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110565/5/obiltoxaximab.
Vallerand AHA, Sanoski CAC. Obiltoxaximab. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110565/5/obiltoxaximab. Accessed June 28, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Obiltoxaximab. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110565/5/obiltoxaximab
Vallerand AHA, Sanoski CAC. Obiltoxaximab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 28]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110565/5/obiltoxaximab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - obiltoxaximab
ID - 110565
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110565/5/obiltoxaximab
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

